Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data.

Cobble, Michael E

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data. [electronic resource] - Cardiovascular diabetology Jan 2012 - 6 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review

1475-2840

10.1186/1475-2840-11-6 doi


Adamantane--adverse effects
Cardiovascular Diseases--etiology
Clinical Trials as Topic
Diabetes Complications--etiology
Diabetes Mellitus, Type 2--complications
Dipeptides--adverse effects
Dipeptidyl-Peptidase IV Inhibitors--adverse effects
Drug Therapy, Combination
Evidence-Based Medicine
Humans
Patient Safety
Proportional Hazards Models
Risk Assessment
Risk Factors
Treatment Outcome